"We want AI inside quality, but we cannot risk an inspection finding." This is the one most clients arrive with, and it is the work I know best.
Your eQMS is digital, yet deviations still take days to author, the same queries get re-answered, and CAPAs repeat. Everyone can see AI would help. No one can tell you how to put it into a GxP process and still defend it to an inspector who has never seen the model. So the pilots stall in a sandbox, and the value stays on the slide.
AI belongs on the highest-volume, lowest-judgment steps first, where it removes manual lift without removing human decision. Each tool is classified by its impact on quality and patient safety and by how much autonomy it holds, then validated to that tier. Every AI-influenced decision records its input, output, reviewer and disposition, so the audit trail tells the whole story on its own. That is the difference between a demo and a deployment.
The structure underneath is the AI Governance Stack: a regulatory spine, a reference architecture, four-tier risk classification, a governance operating model, a validation master plan, and live monitoring. Decision integrity on top of data integrity.
Three named tools, deployed in live GxP quality, taken through a Health Authority inspection with zero digital compliance observations.
Each is validated, monitored for drift, and wrapped in a governance model that an inspector can follow without your help.
Outcomes from a global pharmaceutical client, rewritten as an anonymised engagement. No employer or client is named.
Take the AI-in-GxP Readiness Index, or book a conversation and bring your hardest use case.
Book a discussion Take the readiness index